Press Releases Home - Investor Relations - Press Releases Press Releases Year None2023202220212020201920182017201620152014 Date Title August 2, 2023 Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update July 26, 2023 Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call July 17, 2023 Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH) June 27, 2023 Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer May 3, 2023 Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update April 26, 2023 Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call April 5, 2023 Corcept Therapeutics Announces Final Results of Tender Offer April 3, 2023 Corcept Therapeutics Announces Preliminary Results of Tender Offer March 28, 2023 Corcept Therapeutics Initiates CATALYST Clinical Trial March 6, 2023 Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13 Shareholder Tools Email Alerts Print Page RSS Feeds
Press Releases Year None2023202220212020201920182017201620152014 Date Title August 2, 2023 Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update July 26, 2023 Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call July 17, 2023 Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH) June 27, 2023 Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer May 3, 2023 Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update April 26, 2023 Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call April 5, 2023 Corcept Therapeutics Announces Final Results of Tender Offer April 3, 2023 Corcept Therapeutics Announces Preliminary Results of Tender Offer March 28, 2023 Corcept Therapeutics Initiates CATALYST Clinical Trial March 6, 2023 Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13